Broach Lifecare Hospital Limited has announced its audited standalone financial results for the year and half-year ended March 31, 2026. The Board of Directors approved the results during a meeting held on May 21, 2026. The company reported a net profit of ₹8.68 lakh for the full year, a significant decrease from ₹53.59 lakh in the previous year. For the half-year ended March 31, 2026, the company recorded a net loss of ₹22.53 lakh.

Financial Performance

Revenue from operations for the year ended March 31, 2026, rose to ₹599.47 lakh compared to ₹317.94 lakh in the prior year. Total income for the year stood at ₹603.67 lakh. The company's total expenditure increased to ₹582.62 lakh from ₹250.91 lakh in the previous year, primarily driven by higher costs related to purchases of stock-in-trade and employee benefit expenses.

Operational Highlights

The board noted that there were no deviations in the utilization of proceeds from the company's initial public offering (IPO) during the period from October 1, 2025, to March 31, 2026. The IPO funds were raised on August 19, 2024, totaling ₹402 lakh. The trading window for designated persons, which closed on April 1, 2026, will reopen 48 hours after the declaration of these financial results.

The statutory auditors, M/s. K. K. Haryani & Co, issued an audit report with an unmodified opinion on the standalone financial results. Dr. Jaykumar Narendra Vyas, Managing Director, signed the financial results and compliance certificates on behalf of the company.

Broach Lifecare Hospital Limited has submitted its quarterly compliance certificate under SEBI regulations, demonstrating adherence to regulatory requirements for the quarter ended March 31, 2026. The healthcare company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 with BSE Limited.

Regulatory Compliance Filing

The company submitted the required documentation to BSE Limited on April 14, 2026, confirming compliance with depositories regulations. The filing includes certificates from both Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL), covering the quarter ended March 31, 2026.

Certificate Confirmation

KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent, issued confirmation certificates dated April 1, 2026. The certificates confirm that details of securities dematerialized and rematerialized during the quarter have been furnished to all stock exchanges where the company's shares are listed.

Praveen Chaturvedi, Senior Vice President at KFin Technologies Limited, signed both CDSL and NSDL certificates, certifying compliance with the regulatory requirements.

Company Leadership

Dr. Jaykumar Narendra Vyas, Managing Director with DIN 08736387, signed the compliance filing on behalf of Broach Lifecare Hospital Limited. The documentation was submitted from the company's registered office in Bharuch, Gujarat.

Regulatory Framework

The filing under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 represents a mandatory quarterly compliance requirement. This regulation ensures transparency in the dematerialization and rematerialization process of securities, maintaining investor confidence in the depository system.

The company's compliance with these regulations demonstrates its commitment to maintaining proper corporate governance standards and regulatory adherence in the healthcare sector.